Debopriya Ghosh
Johnson & Johnson (United States)(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, AI in cancer detection, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Enriched Random Forest for High Dimensional Genomic Data(2021)115 cited
- → Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study(2024)98 cited
- → Talquetamab + Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma: Safety and Preliminary Efficacy Results from the Phase 1b MonumenTAL-2 Study(2023)40 cited
- → Big Data-based Smart City Platform(2016)38 cited
- → Data science, learning, and applications to biomedical and health sciences(2017)33 cited
- → Microplastics/nanoplastics released from facemasks as contaminants of emerging concern(2023)31 cited
- → Teclistamab, Daratumumab, and Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Majestec-2 Cohort a and Trimm-2 Studies(2024)22 cited
- → Socio-economic impact on COVID-19 cases and deaths and its evolution in New Jersey(2021)15 cited
- → Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study(2025)15 cited
- → Inaccurate pretreatment staging can impact survival in early stage esophageal adenocarcinoma(2020)10 cited